1
|
Lifestyle Intervention Randomized Controlled Trial for Age-Related Macular Degeneration (AMD-Life): Study Design. Nutrients 2023; 15:nu15030602. [PMID: 36771309 PMCID: PMC9920008 DOI: 10.3390/nu15030602] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2022] [Revised: 01/16/2023] [Accepted: 01/17/2023] [Indexed: 01/27/2023] Open
Abstract
Age-related macular degeneration (AMD) has a strong genetic basis, but environmental factors such as smoking and a healthy diet can decrease the genetic fate by up to 50%. Current guidelines for clinical management include recommendations for a healthy lifestyle and antioxidant supplementation. However, many ophthalmologists do not inform their patients of this AMD-beneficial lifestyle. An important reason is the lack of trust that transition of lifestyle will be feasible in persons of advanced age and lack of methodology to measure lifestyle or its biological effects. To address these issues, we set up the lifestyle intervention study AMD-Life. It aims to investigate whether personalized risk-profiling (including genetic testing) and/or additional coaching can motivate patients to change their lifestyle. It also explores which biomarkers best reflect lifestyle change beneficial for AMD. The first year is a three-arm, self-contained open-label randomized clinical trial. A total of 150 AMD patients aged 55-85 years were randomized into three arms: (A) merely standard recommendations; (B) A conditions plus personalized risk profiling based on genetics and lifestyle, (C) B conditions plus coaching. The second year tests sustainability of lifestyle changes without active intervention. AMD-Life can provide further insight into the relevance of these interventions for the clinical management of AMD.
Collapse
|
2
|
Lorencatto F, Asif S, Francis JJ, Harper AM, Lawrenson JG. Seeing New Opportunities to Help Smokers Quit: A UK National Survey of Optometrist-Delivered Smoking Cessation Behavioral Support Interventions. Nicotine Tob Res 2020; 21:655-662. [PMID: 29660046 DOI: 10.1093/ntr/nty066] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2017] [Accepted: 04/04/2018] [Indexed: 11/14/2022]
Abstract
BACKGROUND Smoking is a risk factor for various eye conditions. Brief smoking cessation interventions have demonstrated effectiveness when delivered by a range of health care professionals. Optometrists are well placed in the community to advise otherwise healthy smokers to quit, yet remain relatively neglected in smoking cessation research and policy. In a national survey, this study investigated self-reported practices of UK optometrists for delivering brief tobacco smoking cessation interventions to patients. METHODS A randomly selected sample of 1200 optometrists out of the 9000 optometrists registered on the UK College of Optometrists database were invited to complete a 40-item, web-based survey assessing: training related to smoking cessation, current practice (ie, the proportion of patients to which components of very brief advice [Ask, Advise, Assist] and other evidence-based smoking cessation behavior change techniques were delivered), and barriers/enablers to intervention delivery. RESULTS In total, 408 (34%) responses were received. Most (83%) optometrists received no training in practical skills for delivering smoking cessation support. A third (34%) routinely assessed smoking status. Fewer self-reported advising smokers to quit (22%), offering assistance (via referral to dedicated services) (3%), or advice on smoking cessation medications (2%). Perceived barriers included insufficient knowledge/training (81%) and time (65%). Optometrists were more likely to assess and advise on smoking cessation if they practiced in Scotland, χ2(2) = 32.95, p < .001; an independent optometry practice, χ2(1) = 4.27, p = .39; or had received smoking cessation training, χ2(1) = 13.1, p < .001. CONCLUSIONS Substantial gaps exist in UK optometrists' current smoking cessation training and practice. Evidence-based training resources are needed to support the implementation of smoking cessation interventions into routine optometry practice. IMPLICATIONS Optometrists are well placed in the community to deliver brief advice interventions to a large population of smokers. This survey provides a comprehensive description of current UK optometry practice related to the provision of evidence-based brief tobacco smoking cessation interventions to patients. Although optometrists perceive advising on smoking cessation as part of their role, numerous substantial gaps in current practice and training remain, which need to be addressed through targeted interventions to increase implementation.
Collapse
Affiliation(s)
- Fabiana Lorencatto
- Centre for Behaviour Change, University College London, London, UK.,Centre for Health Services Research, School of Health Sciences, City, University of London, London, UK
| | | | - Jill J Francis
- Centre for Health Services Research, School of Health Sciences, City, University of London, London, UK
| | - Alice M Harper
- Centre for Health Services Research, School of Health Sciences, City, University of London, London, UK
| | - John G Lawrenson
- Centre for Applied Vision Research, School of Health Sciences, City, University of London, London, UK
| |
Collapse
|
3
|
Asfar T, Lee DJ, Lam BL, Murchison AP, Mayro EL, Owsley C, McGwin G, Gower EW, Friedman DS, Saaddine J. Evaluation of a Web-Based Training in Smoking Cessation Counseling Targeting U.S. Eye-Care Professionals. HEALTH EDUCATION & BEHAVIOR 2017; 45:181-189. [DOI: 10.1177/1090198117709883] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Background. Smoking causes blindness-related diseases. Eye-care providers are uniquely positioned to help their patients quit smoking. Aims. Using a pre-/postevaluation design, this study evaluated a web-based training in smoking cessation counseling targeting eye-care providers. Method. The training was developed based on the 3A1R protocol: “Ask about smoking, Advise to quit, Assess willingness to quit, and Refer to tobacco quitlines,” and made available in the form of a web-based video presentation. Providers ( n = 654) at four academic centers were invited to participate. Participants completed pretraining, posttraining, and 3-month follow-up surveys. Main outcomes were self-reported improvement in their motivation, confidence, and counseling practices at 3-month follow-up. Generalized linear mixed models for two time-points (pretraining and 3-month) were conducted for these outcomes. Results. A total of 113 providers (54.0% males) participated in the study (17.7% response rate). At the 3-month evaluation, 9.8% of participants reported improvement in their motivation. With respect to the 3A1R, 8% reported improvement in their confidence for Ask, 15.5% for Advise, 28.6% for Assess, and 37.8% for Refer. Similarly, 25.5% reported improvement in their practices for Ask, 25.5% for Advise, 37.2% for Assess, and 39.4% for Refer to tobacco quitlines ( p < .001 for all except for Refer confidence p = .05). Discussion. Although participation rate was low, the program effectively improved providers’ smoking cessation counseling practices. Conclusions. Including training in smoking cessation counseling in ophthalmology curriculums, and integrating the 3A1R protocol into the electronic medical records systems in eye-care settings, might promote smoking cessation practices in these settings.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | - Jinan Saaddine
- Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA, USA
| |
Collapse
|
4
|
Register SJ, Harrington KF, Agne AA, Cherrington AL. Effectiveness of Non-Primary Care-Based Smoking Cessation Interventions for Adults with Diabetes: A Systematic Literature Review. Curr Diab Rep 2016; 16:81. [PMID: 27424070 DOI: 10.1007/s11892-016-0777-8] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
Diabetes is a chronic disease that affects over 25 million adults, many of whom are smokers. The negative health impact of diabetes and comorbid smoking is significant and requires comprehensive interdisciplinary management. The National Diabetes Education Program has identified specific providers, known as PPOD, who include pharmacists, podiatrists, optometrists, and dentists, as key individuals to improve diabetes-related clinical outcomes. These providers are encouraged to work together through interdisciplinary collaboration and to implement evidence-based strategies as outlined in the PPOD toolkit. The toolkit encourages healthcare providers to ask, advise, and assist patients in their efforts to engage in risk reduction and healthy behaviors, including smoking cessation as an important risk factor. While individual PPOD providers have demonstrated effective smoking cessation interventions in adults with other acute and chronic systemic diseases, they lack specific application and focus on adults with diabetes. This literature review examines the current role of PPOD providers in smoking cessation interventions delivered to adults with diabetes.
Collapse
Affiliation(s)
- Shilpa J Register
- UAB, Office of Interprofessional Simulation, 619 19th Street South Birmingham, Birmingham, AL, 35294, USA.
| | - Kathy F Harrington
- Department of Pulmonary Medicine, UAB School of Medicine, Birmingham, USA
| | - April A Agne
- Department of Preventive Medicine, UAB School of Medicine, Birmingham, USA
| | | |
Collapse
|
5
|
Lorencatto F, Harper AM, Francis JJ, Lawrenson JG. A survey of
UK
optometry trainees’ smoking cessation training. Ophthalmic Physiol Opt 2016; 36:494-502. [DOI: 10.1111/opo.12290] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2015] [Accepted: 01/29/2016] [Indexed: 11/30/2022]
Affiliation(s)
- Fabiana Lorencatto
- Centre for Health Services Research, School of Health Sciences City University London London UK
| | - Alice M. Harper
- Centre for Health Services Research, School of Health Sciences City University London London UK
| | - Jill J. Francis
- Centre for Health Services Research, School of Health Sciences City University London London UK
| | - John G. Lawrenson
- Centre for Public Health Research, School of Health Sciences City University London London UK
| |
Collapse
|
6
|
Advice about diet and smoking for people with or at risk of age-related macular degeneration: a cross-sectional survey of eye care professionals in the UK. BMC Public Health 2013; 13:564. [PMID: 23759079 PMCID: PMC3695797 DOI: 10.1186/1471-2458-13-564] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2012] [Accepted: 05/30/2013] [Indexed: 12/20/2022] Open
Abstract
Background In the absence of a cure, there has been considerable interest in attempts to prevent or reduce the progression of age-related macular degeneration (AMD) by targeting particular modifiable risk factors. The aim of this study was to conduct a cross-sectional survey of the current practice of UK eye care professionals in relation to advice given on diet and other lifestyle modifications for patients with or at risk of AMD. Methods Optometrists and ophthalmologists on the membership databases of professional organisations for the two professions were invited to participate in an online survey. The survey was open for 12 weeks between July and September 2012. Results A total of 1,468 responses were received (96.3% from optometrists and 3.7% from ophthalmologists). The response rate of those receiving the invitation was 16.2% (1,414/8735) for optometrists and 6% (54/1460) for ophthalmologists. A majority of respondents reported that they frequently provide dietary advice to patients with established AMD (67.9%) and those at risk of AMD (53.6%). Typical advice consisted of a recommendation to eat plenty of leafy green vegetables and eat more oily fish. The decision to recommend nutritional supplements was based on the risk of progression to advanced AMD, with approximately 93% of respondents recommending supplementation in a patient with advanced AMD in one eye. However for the majority, the type of supplement recommended did not comply with current best research evidence, based on the findings of the Age-related Eye Disease Study (AREDS). Only one in three optometrists regularly assessed smoking status and advised on smoking cessation. Conclusions Within a large sample of eye care professionals, consisting predominantly of optometrists, who responded to a cross-sectional survey, there was active engagement in providing nutritional advice to patients with or at risk of AMD. However, the results demonstrate a need to raise awareness of the evidence underpinning the use of nutritional supplements together with an increased involvement in targeted smoking cessation.
Collapse
|
7
|
Awareness of blindness and other smoking-related diseases and its impact on motivation for smoking cessation in eye patients. Eye (Lond) 2011; 25:1170-6. [PMID: 21701524 DOI: 10.1038/eye.2011.143] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
Abstract
PURPOSE Cigarette smoking is a major cause of morbidity and mortality. The association between smoking and eye diseases is less widely recognised relative to other better-known smoking-related conditions. This study aims to assess the awareness and fear of known smoking-related diseases among current smokers attending an ophthalmology outpatient clinic and to evaluate their relative impact on the likelihood of smoking cessation. PATIENTS AND METHODS A cross-sectional survey using a structured interview of randomly selected current smokers attending an eye clinic was conducted. The knowledge of six smoking-related diseases (lung cancer, heart attack, stroke, blindness, other cancers, and other lung diseases) was assessed. The fear of smoking-related conditions and the relative impact of each smoking-related condition on the smoker's motivation to quit smoking were evaluated. RESULTS Out of 200 current smokers aged from 14 to 83 years, only 42.5% (85 patients) were aware that smoking causes blindness. Smokers' perception of harm caused by smoking was 6.53±3.21 (mean±SD) on a visual analogue scale of 0 to 10. Patients placed blindness as the second most important motivating factor to quit smoking immediately, within 1 year and 5 years, after lung cancer. CONCLUSION The awareness of the risk of blindness from smoking was lowest compared with five other smoking-related diseases among eye patients who smoke. However, blindness remains a key motivational factor in smoking cessation and hence should be emphasised as an important negative health consequence of smoking in public health education and anti-smoking campaigns.
Collapse
|
8
|
Thornton J, Torun P, Edwards R, Harrison A, Kelly SP, Harrison RA, Verma A. Smoking cessation support in community pharmacies: is the association of smoking and eye disease an additional tool to increase uptake? INTERNATIONAL JOURNAL OF PHARMACY PRACTICE 2010. [DOI: 10.1211/ijpp.16.4.0007] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
Abstract
Abstract
Objective
Community pharmacists have a central role in provision of smoking-cessation support. Evidence is growing that tobacco smoking is associated with development and progression of several potentially blinding eye diseases. As part of an ongoing programme of raising awareness of this link, we investigated whether community pharmacists are aware of this association and incorporate relevant advice into their smoking-cessation guidance.
Setting
Two-thousand and eighty community pharmacists in north west England, UK.
Method
A postal self-completion questionnaire asked pharmacists about their current practice with regard to smoking habits of their clients. Data were extracted and entered onto a database for statistical analyses.
Key findings
The response rate was 50.5%; 685 (65.2%) pharmacists asked clients about smoking habits; the most common situation was when clients complained of respiratory symptoms. Of these pharmacists, 52.7% always/usually recommended that smokers should stop and 37.2% always/usually assessed motivation to succeed. Help provided by pharmacists included brief advice on smoking cessation, leaflets, more structured support, referral to smoking-cessation services, and nicotine replacement therapies. The most common reason why pharmacists did not ask about smoking was lack of time (83.1%); 52.0% were aware of the causal association of smoking with eye disease, and 19.8% of those who asked about smoking habits mentioned this association when discussing smoking cessation.
Conclusion
Our study shows that community pharmacists are actively involved in smoking cessation. Many pharmacists are aware of the causal association between smoking and eye disease, but few are actively counselling patients about the eye heath risks of smoking. Community pharmacists could include this information in their advice to clients who smoke, as an additional means to promote smoking cessation.
Collapse
Affiliation(s)
- Judith Thornton
- Clinical Epidemiology and Public Health Unit, University of Manchester, UK
| | - Perihan Torun
- Clinical Epidemiology and Public Health Unit, University of Manchester, UK
| | - Richard Edwards
- Department of Public Health, University of Otago, Wellington, New Zealand
| | - Annie Harrison
- Clinical Epidemiology and Public Health Unit, University of Manchester, UK
| | - Simon P Kelly
- Ophthalmology Department, Bolton Hospitals NHS Trust, Bolton, UK
| | - Roger A Harrison
- School of Community Medicine, University of Manchester, Manchester, UK
| | - Arpana Verma
- Clinical Epidemiology and Public Health Unit, University of Manchester, UK
| |
Collapse
|
9
|
Moradi P, Thornton J, Edwards R, Harrison RA, Washington SJ, Kelly SP. Teenagers' perceptions of blindness related to smoking: a novel message to a vulnerable group. Br J Ophthalmol 2007; 91:605-7. [PMID: 17284473 PMCID: PMC1954776 DOI: 10.1136/bjo.2006.108191] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/17/2006] [Indexed: 11/04/2022]
Abstract
BACKGROUND Cigarette smoking often starts in teenage years. It is not known whether teenagers are aware of the association of smoking with eye disease and blindness. AIM To explore the knowledge of the link between smoking, and eye diseases and blindness, and the likely impact of this knowledge among teenagers in UK. METHODS A cross-sectional survey, using a structured interview of teenagers attending four organised social events, was conducted. Awareness and fear of blindness, and of three smoking-related diseases (lung cancer, heart disease and stroke) and a distractor condition (deafness) was investigated. The likelihood of smokers quitting on developing early signs of each condition was determined. RESULTS A 92% "opt in" response rate was achieved. Out of 260 teenagers (16-18 years), 15%, 27% and 81% believed that smoking caused stroke, heart disease and lung cancer, respectively. Only 5% believed smoking caused blindness. Subjects ranked their fear of each of the five conditions, scoring five for the most feared and one for the least feared. Subjects were significantly (p<0.01) more fearful (mean scores in brackets) of blindness (4.2) than of lung cancer (3.4), heart disease (2.3) and deafness (1.2). More teenagers (p<0.01) said they would stop smoking on developing early signs of blindness compared with early signs of lung or heart disease. CONCLUSIONS Awareness of the risk of blindness from smoking is low among teenagers, but fear of blindness may be more likely to motivate teenagers to stop smoking than fear of lung or heart disease. Teenagers should be made more aware of the ocular risks of cigarette smoking as a novel public health measure.
Collapse
Affiliation(s)
- Phillip Moradi
- Bolton Eye Unit, Bolton Hospitals NHS Trust, Bolton BL4 0JR, UK
| | | | | | | | | | | |
Collapse
|